Submitted by Anonymous (not verified) on 16 August 2024 - 13:07
Human medicines European public assessment report (EPAR): Okedi, risperidone, Date of authorisation: 14/02/2022, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Okedi, risperidone, Date of authorisation: 14/02/2022, Revision: 3, Status: Authorised